WHO SMART Guidelines - HIV - Local Development build (v0.4.3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Draft as of 2025-02-02 |
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- a fhir:Library ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "HIVIND29Logic"] ; # fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary> ] [ fhir:v "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary> ] [ fhir:v "http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library> ] [ fhir:v "http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module> ] ) ] ; # fhir:text [ fhir:status [ fhir:v "extensions" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<div>\n <table class=\"grid dict\">\n \n \n <tr>\n <th scope=\"row\"><b>Title: </b></th>\n <td style=\"padding-left: 4px;\">HIV.IND.29 Logic</td>\n </tr>\n \n\n \n \n <tr>\n <th scope=\"row\"><b>Id: </b></th>\n <td style=\"padding-left: 4px;\">HIVIND29Logic</td>\n </tr>\n \n\n \n \n <tr>\n <th scope=\"row\"><b>Version: </b></th>\n <td style=\"padding-left: 4px;\">0.4.3</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Url: </b></th>\n <td style=\"padding-left: 4px;\"><a href=\"Library-HIVIND29Logic.html\">HIV.IND.29 Logic</a></td>\n </tr>\n \n\n \n\n \n\n \n <tr>\n <th scope=\"row\"><b>Status: </b></th>\n <td style=\"padding-left: 4px;\">draft</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Experimental: </b></th>\n <td style=\"padding-left: 4px;\">true</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Type: </b></th>\n <td style=\"padding-left: 4px;\">\n \n \n \n <p style=\"margin-bottom: 5px;\">\n <b>system: </b> <span><a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-library-type.html\">http://terminology.hl7.org/CodeSystem/library-type</a></span>\n </p>\n \n \n <p style=\"margin-bottom: 5px;\">\n <b>code: </b> <span>logic-library</span>\n </p>\n \n \n \n \n \n </td>\n </tr>\n \n\n \n\n \n <tr>\n <th scope=\"row\"><b>Date: </b></th>\n <td style=\"padding-left: 4px;\">2025-02-02 03:11:41+0000</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Publisher: </b></th>\n <td style=\"padding-left: 4px;\">WHO</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Description: </b></th>\n <td style=\"padding-left: 4px;\"><div><p>% of people living with HIV on ART (for at least six months) who have virological suppression</p>\n</div></td>\n </tr>\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n <tr>\n <td colspan=\"2\">\n <table>\n <tr><th><a id=\"cql-content\"><b>Content: </b></a> text/cql</th></tr>\n <tr><td><pre><code class=\"language-cql\">/**\n * Library: HIV.IND.29 Logic\n * Ref No: ART.3\n * Short Name: People living with HIV on ART who have suppressed viral load\n *\n * Definition: % of people living with HIV on ART (for at least six months) who have virological suppression\n *\n * Numerator: Number of people living with HIV on ART for at least six months and with at least one routine VL test result who have virological suppression (<1000 copies/mL*) during the reporting period.\n * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test' AND "Viral load test result" LESS THAN 1000 copies/mL\n * Numerator Exclusions: \n *\n * Denominator: Number of people living with HIV on ART at least six months with at least one routine VL result in a medical or laboratory record during the reporting period, to monitor progress towards the third 95 target | | In addition, this can also be presented as the number with suppressed VL among all people living with HIV to calculate population-level viral suppression.\n * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test'\n * Denominator Exclusions: \n *\n * Disaggregations:\n * • Gender (female, male, other**) \n * • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50+ years)*** \n * • Key populations (men who have sex with men, people living in prisons and other closed settings, people who inject drugs, sex workers, trans and gender diverse people)**** \n * • Cities and other administrative regions of epidemiologic importance\n *\n * Disaggregation Elements: Gender | Age | Key population member type\n *\n * Numerator and Denominator Elements:\n * ART start date \n * Date of viral load sample collection \n * HIV status \n * On ART \n * Reason for HIV viral load test \n * Viral load test result\n *\n * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022\n * \n * Data Concepts:\n * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth\n * HIV.A.DE18: Gender* | Gender of the client*\n * HIV.A.DE19: Female | Client identifies as female\n * HIV.A.DE20: Male | Client identifies as male\n * HIV.A.DE21: Transgender male | Client identifies as transgender male\n * HIV.A.DE22: Transgender female | Client identifies as transgender female\n * HIV.A.DE23: Other | Additional category\n * HIV.B.DE50: Key population member type* | The type of key population that the client is included in\n * HIV.B.DE51: Sex worker | Client is a sex worker\n * HIV.B.DE52: Men who have sex with men | Client is a man who has sex with men\n * HIV.B.DE53: Trans and gender-diverse people | Client identifies as trans and gender-diverse\n * HIV.B.DE54: People who inject drugs | Client is a person who injects drugs\n * HIV.B.DE55: People living in prisons and other closed settings | Client lives in a prison or another closed setting\n * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)\n * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.\n * HIV.B.DE116: HIV-positive | Client is HIV-positive\n * HIV.B.DE117: HIV-negative | Client is HIV-negative\n * HIV.B.DE118: Unknown | Client has unknown HIV status\n * HIV.D.DE38: On ART | Client is currently taking ART\n * HIV.D.DE39: ART start date | The date on which the client started or restarted ART\n * HIV.D.DE194: Date of viral load sample collection | Date and time when the sample was collected to test the client's HIV viral load\n * HIV.D.DE387: Viral load test result | Result from the viral load test in number of copies/mL\n * HIV.D.DE391: Reason for HIV viral load test | Whether the viral load is being tested for routine monitoring on a set schedule or for targeted monitoring for suspected treatment failure\n * HIV.D.DE392: Routine viral load test | Routine refers to viral load tests obtained at standard intervals following ART initiation to monitor viral load response to ART\n * HIV.D.DE393: Targeted viral load monitoring | Targeted refers to viral load tests obtained based on a specific clinical indication (such as concern about disease progression or failure to respond to ART)\n * HIV.D.DE394: Initial viral load test | The first viral load test of the client\n * HIV.D.DE395: Follow-up viral load test after receiving enhanced adherence counselling | A follow-up viral load test within 3-6 months after enhanced adherence counselling after client received a high viral load test result\n * HIV.E.DE114: Key population member type* | The type of key population that the infant's mother is included in\n * HIV.E.DE115: Sex worker | Infant's mother is a sex worker\n * HIV.E.DE116: People who inject drugs | Infant's mother is a person who injects drugs\n * HIV.E.DE117: Trans and gender-diverse people | Infant's mother identifies as trans and gender-diverse\n * HIV.E.DE118: People living in prisons and other closed setting | Infant's mother is in a prison or closed setting\n * HIV.G.DE8: Date of viral load sample collection | Date and time when the sample was collected to test the client's HIV viral load\n * HIV.G.DE12: Viral load test result | Result from the viral load test in number of copies/mL\n * HIV.H.DE47: On ART | Client is currently taking ART \n * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)\n * HIV.SRV.DE12: Date of viral load sample collection | Date and time when the sample was collected to test the client's HIV viral load\n * HIV.SRV.DE13: Viral load test result | Result from the viral load test in number of copies/mL\n *\n * Additional Context\n * - what it measures: Measures clinical outcomes, specifically viral suppression of patients on ART regardless of ART initiation date.\n * - rationale: • Viral load suppression (VLS) represents the expected outcome of ART programme services that is, the third 95 target. | • VLS is also the best available measure of adherence to ART\n * - method: For the numerator and denominator: Patient monitoring tools (for example, ART register, patient records, EMRs, laboratory records) or acquired HIVDR surveillance, population-based surveys (such as, the Population-Based HIV Impact Assessment) that collects data on ART coverage and viral suppression | | This indicator must be interpreted along with VL testing coverage to assess the potential for bias, that is, whether VL testing occurs in only a particular subset of people receiving ART. | | Note: First routine VL testing is recommended at six months after ART initiation. As per ART.7, the time window for early VL monitoring can include a margin of +/– one month, that is, for reporting purposes a routine VL test can take place any time from five to seven months after initiation of ART.\n * \n * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm\n */\n\nlibrary HIVIND29Logic\n\n// Included Libraries\nusing FHIR version '4.0.1'\n\ninclude HIVCommon version '0.0.1' called HIC\ninclude FHIRHelpers version '4.0.1'\ninclude WHOCommon called WCom\ninclude HIVElements called HE\ninclude HIVIndicatorElements called HIE\n\n// Indicator Definition\nparameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]\n\ncontext Patient\n/* Populations */\n\n/*\n *Initial Population\n */\n\ndefine "Initial Population":\n true\n\n/**\n * Numerator\n * \n * Definition: Number of people living with HIV on ART for at least six months and with at least one routine VL test result who have virological suppression (<1000 copies/mL*) during the reporting period.\n * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test' AND "Viral load test result" LESS THAN 1000 copies/mL\n */\n\ndefine "Numerator":\n HIE."Has HIV-positive Status"\n and HIE."On ART H.DE47"\n and \n (months between (end of "Measurement Period") and (date from start of HE."First On ART".effective.toInterval()) > 6 months)\n and \n exists(\n HIE."Viral load test result D.DE387" VL\n with HE."routine viral load sample collection" P \n such that VL.partOf.references(P) and P.performed.toInterval() during "Measurement Period"\n where VL.value < 1000\n )\n\n/**\n * Denominator\n *\n * Definition: Number of people living with HIV on ART at least six months with at least one routine VL result in a medical or laboratory record during the reporting period, to monitor progress towards the third 95 target | | In addition, this can also be presented as the number with suppressed VL among all people living with HIV to calculate population-level viral suppression.\n * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test'\n */\n\ndefine "Denominator":\n HIE."Has HIV-positive Status"\n and HIE."On ART H.DE47"\n and \n (months between (end of "Measurement Period") and (date from start of HE."First On ART".effective.toInterval()) > 6 months)\n and \n exists(\n HIE."Viral load test result D.DE387" VL\n with HE."routine viral load sample collection" P \n such that VL.partOf.references(P) and P.performed.toInterval() during "Measurement Period"\n )\n \n\n/* end Populations */\n\n/*\n * Disaggregators\n */\n\ndefine "Administrative Gender Stratifier":\n HIE."By Administrative Gender Stratifier"\n\ndefine "Age Stratifier":\n HIE."By Age Stratifier"\n\ndefine "Geographic Region Stratifier":\n HIE."By Geographic Region Stratifier"\n\ndefine "patientGroups Stratifier":\n HIE."patientGroups"\n\n\ndefine "Stratification":\n HIE."By Administrative Gender Stratifier".code \n + ':' + HIE."By Age Stratifier"\n+ ':' + HIE."By Geographic Region Stratifier"\n+ Combine(HIE.patientGroups, ':')</code></pre></td></tr>\n </table>\n </td>\n </tr>\n \n \n \n </table>\n</div>\n</div>" ] ; # fhir:extension ( [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability"^^xsd:anyURI ] ; fhir:value [ fhir:v "computable" ] ] ) ; # fhir:url [ fhir:v "http://smart.who.int/hiv/Library/HIVIND29Logic"^^xsd:anyURI] ; # fhir:version [ fhir:v "0.4.3"] ; # fhir:name [ fhir:v "HIVIND29Logic"] ; # fhir:title [ fhir:v "HIV.IND.29 Logic"] ; # fhir:status [ fhir:v "draft"] ; # fhir:experimental [ fhir:v "true"^^xsd:boolean] ; # fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/library-type"^^xsd:anyURI ] ; fhir:code [ fhir:v "logic-library" ] ] ) ] ; # fhir:date [ fhir:v "2025-02-02T03:11:41+00:00"^^xsd:dateTime] ; # fhir:publisher [ fhir:v "WHO"] ; # fhir:contact ( [ fhir:name [ fhir:v "WHO" ] ; ( fhir:telecom [ fhir:system [ fhir:v "url" ] ; fhir:value [ fhir:v "http://who.int" ] ] ) ] ) ; # fhir:description [ fhir:v "% of people living with HIV on ART (for at least six months) who have virological suppression"] ; # fhir:content ( [ fhir:contentType [ fhir:v "text/cql" ] ; fhir:data [ fhir:v "/**
 * Library: HIV.IND.29 Logic
 * Ref No: ART.3
 * Short Name: People living with HIV on ART who have suppressed viral load
 *
 * Definition: % of people living with HIV on ART (for at least six months) who have virological suppression
 *
 * Numerator: Number of people living with HIV on ART for at least six months and with at least one routine VL test result who have virological suppression (<1000 copies/mL*) during the reporting period.
 * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test' AND "Viral load test result" LESS THAN 1000 copies/mL
 * Numerator Exclusions: 
 *
 * Denominator: Number of people living with HIV on ART at least six months with at least one routine VL result in a medical or laboratory record during the reporting period, to monitor progress towards the third 95 target |  | In addition, this can also be presented as the number with suppressed VL among all people living with HIV to calculate population-level viral suppression.
 * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test'
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (female, male, other**) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50+ years)*** 
 *  • Key populations (men who have sex with men, people living in prisons and other closed settings, people who inject drugs, sex workers, trans and gender diverse people)**** 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age | Key population member type
 *
 * Numerator and Denominator Elements:
 * ART start date 
 *  Date of viral load sample collection 
 *  HIV status 
 *  On ART 
 *  Reason for HIV viral load test 
 *  Viral load test result
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE50: Key population member type* | The type of key population that the client is included in
 * HIV.B.DE51: Sex worker | Client is a sex worker
 * HIV.B.DE52: Men who have sex with men | Client is a man who has sex with men
 * HIV.B.DE53: Trans and gender-diverse people | Client identifies as trans and gender-diverse
 * HIV.B.DE54: People who inject drugs | Client is a person who injects drugs
 * HIV.B.DE55: People living in prisons and other closed settings | Client lives in a prison or another closed setting
 * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
 * HIV.B.DE116: HIV-positive | Client is HIV-positive
 * HIV.B.DE117: HIV-negative | Client is HIV-negative
 * HIV.B.DE118: Unknown | Client has unknown HIV status
 * HIV.D.DE38: On ART | Client is currently taking ART
 * HIV.D.DE39: ART start date | The date on which the client started or restarted ART
 * HIV.D.DE194: Date of viral load sample collection | Date and time when the sample was collected to test the client's HIV viral load
 * HIV.D.DE387: Viral load test result | Result from the viral load test in number of copies/mL
 * HIV.D.DE391: Reason for HIV viral load test | Whether the viral load is being tested for routine monitoring on a set schedule or for targeted monitoring for suspected treatment failure
 * HIV.D.DE392: Routine viral load test | Routine refers to viral load tests obtained at standard intervals following ART initiation to monitor viral load response to ART
 * HIV.D.DE393: Targeted viral load monitoring | Targeted refers to viral load tests obtained based on a specific clinical indication (such as concern about disease progression or failure to respond to ART)
 * HIV.D.DE394: Initial viral load test | The first viral load test of the client
 * HIV.D.DE395: Follow-up viral load test after receiving enhanced adherence counselling | A follow-up viral load test within 3-6 months after enhanced adherence counselling after client received a high viral load test result
 * HIV.E.DE114: Key population member type* | The type of key population that the infant's mother is included in
 * HIV.E.DE115: Sex worker | Infant's mother is a sex worker
 * HIV.E.DE116: People who inject drugs | Infant's mother is a person who injects drugs
 * HIV.E.DE117: Trans and gender-diverse people | Infant's mother identifies as trans and gender-diverse
 * HIV.E.DE118: People living in prisons and other closed setting | Infant's mother is in a prison or closed setting
 * HIV.G.DE8: Date of viral load sample collection | Date and time when the sample was collected to test the client's HIV viral load
 * HIV.G.DE12: Viral load test result | Result from the viral load test in number of copies/mL
 * HIV.H.DE47: On ART | Client is currently taking ART 
 * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 * HIV.SRV.DE12: Date of viral load sample collection | Date and time when the sample was collected to test the client's HIV viral load
 * HIV.SRV.DE13: Viral load test result | Result from the viral load test in number of copies/mL
 *
 * Additional Context
 * - what it measures: Measures clinical outcomes, specifically viral suppression of patients on ART regardless of ART initiation date.
 * - rationale: • Viral load suppression (VLS) represents the expected outcome of ART programme services that is, the third 95 target. | • VLS is also the best available measure of adherence to ART
 * - method: For the numerator and denominator: Patient monitoring tools (for example, ART register, patient records, EMRs, laboratory records) or acquired HIVDR surveillance, population-based surveys (such as, the Population-Based HIV Impact Assessment) that collects data on ART coverage and viral suppression |  | This indicator must be interpreted along with VL testing coverage to assess the potential for bias, that is, whether VL testing occurs in only a particular subset of people receiving ART. |  | Note: First routine VL testing is recommended at six months after ART initiation. As per ART.7, the time window for early VL monitoring can include a margin of +/– one month, that is, for reporting purposes a routine VL test can take place any time from five to seven months after initiation of ART.
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND29Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include WHOCommon called WCom
include HIVElements called HE
include HIVIndicatorElements called HIE

// Indicator Definition
parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define "Initial Population":
  true

/**
 * Numerator
 * 
 * Definition: Number of people living with HIV on ART for at least six months and with at least one routine VL test result who have virological suppression (<1000 copies/mL*) during the reporting period.
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test' AND "Viral load test result" LESS THAN 1000 copies/mL
 */

define "Numerator":
 HIE."Has HIV-positive Status"
  and HIE."On ART H.DE47"
  and 
   (months between (end of "Measurement Period") and (date from start of HE."First On ART".effective.toInterval()) > 6 months)
   and 
   exists(
    HIE."Viral load test result D.DE387" VL
    with HE."routine viral load sample collection" P 
    such that VL.partOf.references(P) and P.performed.toInterval() during "Measurement Period"
    where VL.value < 1000
    )

/**
 * Denominator
 *
 * Definition: Number of people living with HIV on ART at least six months with at least one routine VL result in a medical or laboratory record during the reporting period, to monitor progress towards the third 95 target |  | In addition, this can also be presented as the number with suppressed VL among all people living with HIV to calculate population-level viral suppression.
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True and "ART start date" GREATER THAN 6 months before reporting period end date AND "Date of viral load sample collection" within reporting period AND "Reason for HIV viral load test"='Routine viral load test'
 */

define "Denominator":
 HIE."Has HIV-positive Status"
  and HIE."On ART H.DE47"
  and 
   (months between (end of "Measurement Period") and (date from start of HE."First On ART".effective.toInterval()) > 6 months)
   and 
   exists(
    HIE."Viral load test result D.DE387" VL
    with HE."routine viral load sample collection" P 
    such that VL.partOf.references(P) and P.performed.toInterval() during "Measurement Period"
    )
    

/* end Populations */

/*
 * Disaggregators
 */

define "Administrative Gender Stratifier":
	HIE."By Administrative Gender Stratifier"

define "Age Stratifier":
	HIE."By Age Stratifier"

define "Geographic Region Stratifier":
	HIE."By Geographic Region Stratifier"

define "patientGroups Stratifier":
	HIE."patientGroups"


define "Stratification":
 HIE."By Administrative Gender Stratifier".code 
  + ':' + HIE."By Age Stratifier"
+ ':' + HIE."By Geographic Region Stratifier"
+ Combine(HIE.patientGroups, ':')"^^xsd:base64Binary ] ] ) . #
IG © 2025+ WHO. Package smart.who.int.hiv#0.4.3 based on FHIR 4.0.1. Generated 2025-02-02
Links: Table of Contents |
QA Report
| Version History | License